Previous Article | Next Article ![]()
Journal of Virology, July 2007, p. 7716-7724, Vol. 81, No. 14
0022-538X/07/$08.00+0 doi:10.1128/JVI.00549-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Kimberley S. Nixon,
Savithra D. Senanayake,
and
David A. Brian*
Departments of Microbiology and Pathobiology, University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee 37996-0845
Received 15 March 2007/ Accepted 26 April 2007
|
|
|---|
|
|
|---|
Three cis-replication elements have been identified in the 289-nucleotide (nt) BCoV 3' UTR: (i) a bulged stem-loop beginning just downstream from the stop codon of the N gene (20, 21) and an adjacent pseudoknot (45), which possibly together act as a single higher-order molecular switch (14). The bulged stem-loop was first identified in the MHV genome (20-22). An important part of the switch concept derives from the existence of a 5-nt sequence that can function as a component of either the bulged stem-loop or the pseudoknot, but not both simultaneously (14). The bulged stem-loop-pseudoknot structure appears as a common feature among group 2 coronaviruses and has been analyzed in most detail in the context of the MHV genome (14). (ii) A complex bulged stem-loop near the 3' terminus of the 3' UTR, which contains the coronavirus common GGAAGAGC octamer sequence and an adjacent helical region (H. Y. Wu and D. A. Brian, unpublished). This structure was first identified in an MHV DI RNA (47). (iii) A 3'-terminal poly(A) tail (42; S. D. Senanayake and D. A. Brian, unpublished). Interestingly, to date only cellular proteins have been shown to interact with the 3' UTR structures, and of these, only the 3'-terminal octamer-associated bulged stem-loop region (32, 47, 48) and the poly(A) tail (42) have been shown to be targets. The cis-acting functions of the 3' UTR elements may be common among the group 2 coronaviruses, since the BCoV DI RNA can replicate with the helper function of several group 2 coronaviruses (46), and the entire 3' UTR of the BCoV and of human severe acute respiratory syndrome-associated coronavirus (SARS-CoV) can functionally replace the 3' UTR in the MHV genome (16, 21).
Three cis-replication elements have been identified in the 210-nt BCoV 5' UTR. (i) The 5'-terminal 90-nt region harbors stem-loops SLI (nt 11 to 42) and SLII (nt 51 to 84) as predicted by the Tinoco algorithm and as supported by structure probing (8, 9). 5'-terminal deletions of up to 13 nt kill DI RNA replication (8), and other mutations made within the first 90 nt rapidly revert to the wild-type (wt) sequence (9) by a high-frequency recombination event with the helper virus genome, known as leader switching (28). Thus, it appears that the sequence and/or the stem-loops are a cis-acting feature. A recent report described two stem-loops in the region of nt 1 to 51 and, of these, the second functions as a cis-replication element in the context of the MHV genome (24). (ii) SLIII (nt 97 to 116) is predicted by both the Tinoco and Zuker algorithms, is supported by RNase structure probing, and appears to have a homolog in coronavirus groups 1 to 3 (34). In essentially all coronaviruses examined, a translation initiation codon for a short intra-5' UTR open reading frame (ORF) of unknown function is associated with SLIII (34). Base covariations in the helical stem indicate that SLIII is phylogenetically conserved among group 2 coronaviruses (34 and data not shown). (iii) SLIV (nt 186 to 215) is a cis-acting phylogenetically conserved structure in group 2 coronaviruses with the exception of SARS-CoV (35). The structure of SLIV in SARS-CoV appears similar to those predicted for group 1 coronaviruses (35).
During initial studies to determine the structural requirements for BCoV DI RNA replication, it was learned that translation of the continuous ORF within the DI RNA was necessary for replication (7). Beyond this, it has not been determined how the partial nsp1 coding sequence functions in DI RNA replication. Interestingly, an analogous region of the nsp1 coding sequence is found in all naturally occurring and in one synthetically created coronavirus DI RNAs described to date (reviewed in reference 3). In addition, in the context of the MHV genome, a deletion of the 5'-proximal region of the nsp1 coding sequence, but not of the 3'-proximal region, prevents genome replication as determined through reverse genetics analyses (6). The mechanistic contribution of this sequence was not determined, but it was speculated to be perhaps a function of the protein product, an RNA structure, or both (6).
In this study, we have examined the function of the 5'-proximal 288 nt of the nsp1 coding region in the DI RNA ORF that provides replication competence to the BCoV DI RNA. We observed that (i) the 5'-terminal 186 nt of the nsp1 coding region are necessary and sufficient for DI RNA replication, (ii) within the 186-nt sequence are found two Mfold-predicted stem-loops, named SLV (nt 239 to 310) and SLVI (nt 311 to 340), that are supported by RNase structure probing and by nucleotide covariations that maintain the helical stems among the closely related group 2 coronaviruses, and (iii) SLVI is a required higher-order structure for DI RNA replication on the basis of mutation analyses. The function of SLV has not been evaluated. We conclude that SLVI within the BCoV nsp1 coding region acts as a higher-order cis-replication element for DI RNA and postulate that it functions similarly in the viral genome.
|
|
|---|
![]() View larger version (18K): [in a new window] |
FIG. 1. Location of cis-replication elements within the partial nsp1 coding region in BCoV DI RNA. A. Structure of the naturally occurring BCoV DI RNA relative to the full-length BCoV genome. The DI RNA is composed of the fused ends of the viral genome as described in the text. The 65-nt leader is illustrated by a filled rectangle. The partial nsp1 sequence in parentheses represents the 5'-proximal 288 nt of the 738-nt nsp1 coding region. The cloned, modified BCoV DI RNA is under control of the T7 RNA polymerase promoter, carries a 30-nt in-frame reporter used for Northern probing, and is named pDrep1. Restriction endonuclease sites used for further engineering as described in this report are depicted. The cloned, modified BCoV N mRNA (mRNA 7) is under control of the same promoter as pDrep1, carries the same reporter, and is named pNrep2. The difference in the RNA transcripts from the two plasmids both linearized at the MluI site is a continuous sequence of 421 nt as depicted. At the right are shown the results of Northern analyses depicting the accumulation of pDrep1 RNA at 48 and 96 h posttransfection and at 24 hpi following first virus passage (VP1), and the absence of accumulation of the pNrep2 RNA. RNA, 1 ng of transcript used for transfection. B. Structures of modified pDrep1 that carry the 5' UTR of mRNA 7, named p77Drep, and the 5' UTR of the genome but without the 288-nt region of nsp1, named p210Nrep. At the right are Northern analyses depicting the accumulation of wt DI RNA and the absence of accumulation for RNAs from p77Drep and p210Nrep. RNA, 1 ng of transcript used for transfection. C. Deletion analysis of the 288-nt partial nsp1 coding region in BCoV DI RNA. 3'-terminal deletions of the partial nsp1 coding region were made as indicated, and RNAs from the mutants were tested for accumulation. The results of Northern analyses at the right illustrate that DI RNAs carrying the first 186 nt of nsp1 coding region accumulated, whereas those with less than 186 nt did not. RNA, 1 ng of transcript used for transfection.
|
40 µg of a 595-nt-long vector-free transcript was obtained. RNA was treated with 10 U of RNase-free DNase (Promega) at 37°C for 30 min, extracted with phenol-chloroform, chromatographed through a Biospin 6 column (Bio-Rad), spectrophotometrically quantified, and stored in water at 20°C. For RNase treatments, 40 µg of RNA was heat denatured at 65°C for 3 min and renatured by slow cooling (0.5 h) to 35°C in a 400-µl reaction volume containing 30 mM Tris HCl (pH 7.5)-20 mM MgCl2-300 mM KCl, and aliquots containing 2 µg of sample RNA and 10 µg of yeast tRNA were incubated in 100 µl of the same buffer and 1.0, 0.1, 0.05, 0.01, or 0.001 U of RNase CV1 (Pharmacia) or 5.0, 1.0, or 0.1 U of RNase T2 (GIBCO), as noted below in the legend to Fig. 3. RNase digestion was carried out at 25°C for 15 min and terminated by the addition of 150 µl of 0.5 M sodium acetate, after which the RNA was extracted with phenol-chloroform and ethanol precipitated. Digested RNA preparations were used in primer extension reactions with 5'-end-labeled plus-strand-binding primer 1 (BCoV332-352 for mapping SLV) or primer 2 (BCoV379-400 for mapping SLVI) (Table 1). Undigested RNA was used with the same primers to identify natural reverse transcription stops and in dideoxynucleotidyl sequencing reactions to mark nucleotide positions. Products were analyzed on a DNA sequencing gel of 6% polyacrylamide.
![]() View larger version (32K): [in a new window] |
FIG. 3. Enzyme structure probing of SLV and SLVI in BCoV. A. Schematic summary of structure probing data. B. Electrophoretic analysis of digestion products in the SLV region from extensions of primer 1. Lanes 1 through 4, sequencing ladder generated from primer 1; lanes 5 through 8, RNase CV1 digestion with 1.0, 0.1, 0.05, and 0.01 U, respectively; lanes 9 through 11, RNase T2 digestion with 5.0, 1.0, and 0.1 U, respectively; lane 12, undigested RNA. C. Electrophoretic analysis of digestion products in the SLVI region from extensions of primer 2. Lanes 1 through 4, sequencing ladder generated from primer 2; lanes 5 through 7, RNase CV1 digestion with 0.1, 0.01, and 0.01 U, respectively; lanes 8 and 9, RNase T2 digestion with 1.0 and 0.1 U, respectively.
|
|
View this table: [in a new window] |
TABLE 1. Oligonucleotides used in this study
|
To make p77Drep, the 210-nt 5' UTR in pDrep1 was shortened by overlap mutagenesis wherein the products from primers PGEM3Z2097(-), BCoV47-74(+), DI211-232(-), and oligo 2(+) were extended, and the mutated 1,158-nt NdeI fragment from the extended product (the upstream NdeI site is within the vector) was used to replace the analogous fragment in pDrep1. To make p210Nrep, pNrep2 (8) was digested with BglII, and the resulting 754-nt BglII fragment was used to replace the analogous fragment in pDrep1.
3'-end deletions of the 288-nt partial nsp1 coding region within pDrep1 were made by overlap PCR mutagenesis wherein primers Nstart(-) and oligo 2(+) were used to make the 3'-proximal overlapping fragment and primers PGEM3Z2477(-) and the indicated mutant primers (Table 1) were used to make the 5'-proximal overlapping fragments of differing lengths. The mutated HpaI-XbaI fragments from the final extended PCR products were used to replace the analogous fragment in pDrep1. The name of each deletion mutant corresponds to the primer used with the same name.
pLeftVI was made by PCR overlap mutagenesis wherein primers PGEM3Z2477(-), Leftvi(+), Leftvi(-), and oligo 2(+) were used to make an overlap PCR product from which the mutated 1,158-nt NdeI fragment was used to replace the analogous fragment in pDrepl. pRightVI was made in the same way except for the use of primers Rightvi(+) and Rightvi(-), respectively.
In vitro translation.
For in vitro translation,
2 µg of transcript was translated in a 50-µl reaction mix containing 35 µl of rabbit reticulocyte lysate (Promega) and 20 µCi of [35S]methionine (>800 Ci/mmol; MP Biochemicals) as recommended by the manufacturer. Radiolabeled proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in gels of 12% polyacrylamide (Tris-HCl Ready gel; Bio-Rad) by the method of Laemmli (25), and dried gels were exposed to Kodak XAR-5 film for imaging.
Northern assay for DI RNA replication.
The Northern assay for detecting reporter-containing DI RNAs was performed as described previously (8, 33). Briefly, 5 µg of MluI-linearized plasmid DNA was blunt ended with mung bean nuclease and transcribed with 40 U of T7 RNA polymerase (Promega) in a 100-µl reaction mixture to produce uncapped DI RNA. The reaction mix was treated with 5 U of RNase-free DNase (Promega), and RNA was chromatographed through a Biospin 6 column (Bio-Rad) and quantitated spectrophotometrically. Cells (
6 x 106) at
80% confluence in a 35-mm dish were infected with BCoV at a multiplicity of 10 PFU per cell and transfected 1 h later with 1 µg of RNA using Lipofectin (Bethesda Research Laboratories). At the indicated times postinfection, RNA (approximately 10 µg per plate) was extracted by the Nonidet P-40-proteinase K method (8) and stored as an ethanol precipitate. For passage of progeny virus, supernatant fluids were harvested at 48 h postinfection (hpi), and 500 µl was used to infect freshly confluent cells (
8 x 106) in a 35-mm dish from which RNA was extracted at 48 hpi. For electrophoretic separation of RNA in a formaldehyde-agarose gel, 2.5 µg per lane was used. Approximately 1 ng of transcript, identified as RNA in the Northern blot figures, was loaded per lane when used as a marker. RNA was transferred to Nytran membrane by vacuum blotting, and the UV-irradiated blots were probed with oligonucleotide TGEV(+) that had been 5'-end labeled with 32P to specific activities of 1 x 106 to 4 x 107 cpm/pmol. Probed blots were exposed to Kodak XAR-5 film for 1 to 7 days at 80°C for imaging.
Reverse transcription-PCR and sequence analysis of mutant DI RNA replicons. With RNA extracted from cells at 24 h postinfection with VP1 virus collected from mutant transfections, reverse transcription was done using DI RNA-specific primer TGEV(+), PCR was done using primers TGEV(+) and leader(-), and the PCR product was sequenced directly.
|
|
|---|
cis-acting signals for DI RNA replication map within the 5'-terminal 186 nt of the partial nsp1 coding region in the DI RNA, a region containing SLV and SLVI. To characterize the cis-acting features within the 288-nt partial nsp1 coding region, conserved sequences and higher-order structures among eight group 2 coronaviruses previously studied (BCoV-Mebus, human coronavirus [HCoV]-OC43, HCoV-4408, porcine hemagglutinating encephalomyocarditis [HEV]-TN11, equine coronavirus [ECoV]-NC99, classed as BCoV-like, and mouse hepatitis coronavirus [MHV-A59, MHV-2, and MHV-JHM], classed as MHV-like [46]), were identified and treated as potential cis-acting elements. For this, sequences were aligned (46) and the Mfold program of Zuker applied to each. Four predicted hairpin stem-loops showing nucleotide variations in the helical stems among the eight viruses were identified and named SLV through SLVIII (Fig. 2). This nomenclature continues that used for BCoV 5'-proximal stem-loops (7, 8, 34, 35). In BCoV, SLV maps at nt 239 to 310, SLVI at nt 311 to 340, SLVII at nt 356 to 373, and SLVIII at nt 378 to 446, and the calculated free energies are 27.1, 10.9, 2.9, and 26.4 kCal/mol, respectively (Fig. 2). Identical bases aligning among the eight coronaviruses are shown in Fig. 2, and those that differ are identified. Although the SARS-CoV has been classified as a group 2 coronavirus (41), structural homologues of stem-loops V to VIII in SARS-CoV were not apparent by these analyses (data not shown).
![]() View larger version (21K): [in a new window] |
FIG. 2. Stem-loops in the 5'-proximal 288 nt of the 738-nt nsp1 coding region as predicted by Mfold. Named nucleotides are those in BCoV. Unless otherwise indicated, they are also the nucleotides in the other named group 2 coronaviruses and are highlighted in gray. Arrows identify bases in MHV-A59, MHV-2, and MHV-JHM unless otherwise identified by superscipts. The compared group 2 coronaviruses and their superscript designations, if any, are BCoV-Mebus, HCoV-OC43 (o), HCoV-4408, HEV-TN11 (h), ECoV-NC99 (e), MHV-A59 (a), MHV-2 (2), and MHV-JHM (j). The free energies noted refer to the stem-loops in the BCoV RNA.
|
478-498 through 1a
397-498 replicated, as evidenced by accumulation of DI RNA after VP1 and VP2, whereas 1a
358-498 through 1a
217-498 did not. A low level of DI RNA accumulation prior to virus passage posttransfection (for example, the undetectable amounts for mutant p454-498 at 24 h and 48 h posttransfection in Fig. 1C) may reflect structural influences on replication, but we noted that amounts of accumulation at these times did vary widely, even for wt DI RNA (e.g., compare Fig. 1 and 4, below). Thus, for DI RNA replication, the 3'-terminal 102 nt of the 288-nt partial nsp1 coding region, which contains most of SLVIII, are not needed. It was therefore concluded that the SLV- to SLVII-containing 5'-proximal 186-nt region contains one or more cis-acting elements required for DI RNA replication. Of these, SLV and SLVI were chosen for further analysis since they possessed relatively low free energies and demonstrated sequence conservation in the stems.
![]() View larger version (24K): [in a new window] |
FIG. 4. Effects of SLVI mutations on accumulation of BCoV DI RNA. A. Mutations used to test the cis-requirement of SLVI for DI RNA replication. B. Northern analysis to measure the accumulation of wt and SLVI mutant DI RNAs. The 32P-labeled oligonucleotide probe specific for the 30-nt TGEV reporter sequence in the DI RNAs was used. RNA, 1 ng of transcript used for transfection. C. Translation of wt and mutant DI RNAs. T7 RNA polymerase-generated transcripts of wt and mutant DI RNA were translated in rabbit reticulocyte lysate in the presence of 35S-labeled methionine, and the dried gel was autoradiographed. Lane 1, high-molecular-weight Rainbow marker proteins (Amersham); lane 6, translation product from a reaction mixture to which no RNA was added.
|
The mapping results for SLVI as observed via extension of primer 2 (Fig. 3C) show strong single-strand hits at nt 321 to 325, which represent 5 of the 10 nt in the predicted terminal loop. Strong double-strand hits were present at nt 317 to 319, a region predicted to be in the upper stem.
Thus, RNase probing with T2 and CV1 RNases overall yielded results consistent with the stem-loop V and VI structures predicted by Mfold.
Mutation analyses show that SLVI plays a functional role in DI RNA replication. Between SLV and SLVI, SLVI was chosen for testing a cis-replication function since it is relatively small and lends itself to translationally silent stem-disrupting nucleotide changes. It also demonstrated a high level of nucleotide sequence conservation in its upper stem compared with other group 2 coronaviruses (46) (Fig. 2).
To test the replication function of SLVI, base substitutions were made in the third (wobble) nucleotide positions of four base-paired codons in the upper stem that were predicted to disrupt helical structure but preserve wild-type amino acid sequence (Fig. 4A). In construct pLeftVI, substitutions 315G
A and 318G
C were made, and following transfection of transcripts into virus-infected cells no DI RNA accumulation was observed at 24 and 48 h posttransfection, nor was replication observed at 24 h following the first passage of virus (Fig. 4B, LVI). Likewise, when mutations 333C
G and 336C
T were made to form pRightVI, no replication was observed (Fig. 4B, RVI). However, when compensatory restoration of stem-loop VI was made by combining the mutations in pLeftVI and pRightVI, replicating ability was restored as evidenced by the accumulation of DI RNA at 24 and 48 h posttransfection and by replication following the first virus passage (Fig. 4B, L/RVI). Sequence analysis of cDNA clones made from VP1 RNA of the replicating L/RVI double mutant demonstrated that all four mutations were retained (data not shown).
Since the mutations made in SLVI resulted in codons used in the BCoV genome (57% of the time for GAA [Glu], 8% of the time for GUC [Val], 2.6% of the time [19 times total] for UCG [Ser], and 48% of the time for ACU [Thr]), it was not anticipated that blocks in DI RNA replication would result from failed translation of the mutated DI RNA ORFs. To establish that translation was not blocked by the mutations, transcripts of the mutant DI RNAs were translated in rabbit reticulocyte lysate, and the products were examined. The results shown in Fig. 4C demonstrate that wt and all three mutant forms of DI RNA are translated to generate the fused DI RNA ORF product of approximately 62 kDa. The apparent larger size for this protein is due to its phosphorylation (data not shown).
From these combined results, it was concluded that stem-loop VI, as a higher-order structure, is a required cis-acting element for BCoV DI RNA replication.
Whether SLV functions similarly remains to be determined.
|
|
|---|
Whether SLVI is the only directly acting cis RNA replication element within the 5'-terminal region of ORF 1a remains to be determined. SLV is a complex stem-loop that shows considerable structural conservation among the group 2 coronaviruses but has yet to be examined for a cis-replication function. Curiously, like SLVI, the terminal loop of SLV appears to be the most variable part of its structure. The proximity of SLV and SLVI suggests they may be components of a single larger cis-acting structure.
It also remains to be determined what role the protein moiety of the partial nsp1 product plays as a cis-acting feature, if any. It was initially thought that translation of the partial ORF 1a sequence in the BCoV DI RNA is also required for replication (7). Replacing the AUG start codon for the partial nsp1 ORF in DI RNA with a UAG stop codon resulted in no DI RNA replication, even when the N portion of the DI RNA ORF remained open (7). The notion that translation of the partial nsp1 ORF is required for DI RNA replication has been supported by two additional experiments in which the amino acid composition within short regions of the partial nsp1 product was changed and tested. In the first mutant, a nucleotide deletion at position 223 (causing a 1 frameshift) and a nucleotide insertion at position 304 (causing a +1 frameshift) caused amino acids 5 through 31 to change from 5NKYGLELHWAPEFPWMFEDAEEKLDNP31 in the wt DI RNA to 5TNTVSNYTGLQNFHGCLRTQRRSWITL31 in the mutant. In the second mutant, a nucleotide deletion at position 270 (causing a 1 frameshift) and a nucleotide insertion at position 304 (causing a +1 frameshift) caused amino acids 20 through 31 to change from 20MFEDAEEKLDNP31 in the wt DI RNA to 20CLRTQRRSWITL31 in the mutant. Both of these mutations map within the region of SLV. Neither mutant replicated (data not shown). Thus, it could be that a feature of the translated partial nsp1 product fulfills a cis-requirement for replication, but it cannot be ruled out at this time that the nucleotide insertions and deletions altered a required cis-acting RNA structure.
To date, nsp1 has been the most characterized in MHV and SARS-CoV. In MHV, nsp1 is a 28-kDa protein, also called p28, the first proteolytically cleaved product of the polyprotein synthesized from ORF 1a (12). When p28 is expressed in the absence of the other viral proteins, it has profound effects on cell metabolism, including the induction of cell cycle arrest at G0/G1 (10). Interestingly, by using reverse genetics it was shown that the C-terminal region of p28 is not absolutely required for virus replication but that deletion of the N-terminal region is lethal for the virus (6). Expression of the SARS-CoV nsp1 protein alone in cells promoted host mRNA degradation (23).
The identification of cis-replication elements in the large coronavirus genome remains a technical challenge but is now approachable with the use of reverse genetics systems (reviewed in reference 29). An important caveat when using DI RNAs for this identification is that such elements might be idiosyncratic for the DI RNA genome. One example of this is the coronavirus common octamer (GGAAGAGC) in the 3' UTR which functions as a cis-replication element in DI RNA but not in the full-length genome (15). On the basis of the work presented here, we suggest that the presence of a cis-acting element for genome replication mapping within the 5'-proximal region of nsp1 may be one reason the 5'-proximal region of nsp1 cannot be deleted from the intact MHV genome (6). The presence of a cis-acting element within the partial nsp1 coding region along with SLIII and -IV in the BCoV 5' UTR could also explain why it is that the sgmRNAs produced by this virus, although they are found in double-stranded RNA-synthesizing transcriptive intermediates (1, 37), are not replicating molecules as once postulated (17, 39, 40).
Published ahead of print on 2 May 2007. ![]()
Present address: University of Tennessee, Chattanooga, Chattanooga, TN 37408. ![]()
Present address: Crowder College, Neosho, MO 64850. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»